129 related articles for article (PubMed ID: 8032948)
21. Dopamine release during stress in the prefrontal cortex of the rat decreases with age.
Del Arco A; Segovia G; Mora F
Neuroreport; 2001 Dec; 12(18):4019-22. PubMed ID: 11742231
[TBL] [Abstract][Full Text] [Related]
22. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
23. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
[TBL] [Abstract][Full Text] [Related]
24. Effect of morphine on striatal dopamine metabolism and ascorbic and uric acid release in freely moving rats.
Enrico P; Esposito G; Mura MA; Fresu L; De Natale G; Miele E; Desole MS; Miele M
Brain Res; 1997 Jan; 745(1-2):173-82. PubMed ID: 9037407
[TBL] [Abstract][Full Text] [Related]
25. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
[TBL] [Abstract][Full Text] [Related]
26. Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized rat.
Ruggeri M; Ungerstedt U; Agnati LF; Mutt V; Härfstrand A; Fuxe K
Neurochem Int; 1987; 10(4):509-20. PubMed ID: 20501123
[TBL] [Abstract][Full Text] [Related]
27. Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis.
Imperato A; Di Chiara G
J Neurosci; 1985 Feb; 5(2):297-306. PubMed ID: 2857776
[TBL] [Abstract][Full Text] [Related]
28. Destruction of noradrenergic terminals increases dopamine concentration and reduces dopamine metabolism in the medial prefrontal cortex.
Gálosi R; Petykó Z; Kállai V; Tóth A; Ollmann T; Péczely L; Kovács A; Berta B; Lénárd L
Behav Brain Res; 2018 May; 344():57-64. PubMed ID: 29454007
[TBL] [Abstract][Full Text] [Related]
29. Different modifications of the dopamine metabolism in the core and shell parts of the nucleus accumbens following CCK-A receptor stimulation in the shell region.
Ladurelle N; Durieux C; Roques BP; Daugé V
Neurosci Lett; 1994 Aug; 178(1):5-10. PubMed ID: 7816338
[TBL] [Abstract][Full Text] [Related]
30. Lipopolysaccharide increases degradation of central monoamines: an in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice.
van Heesch F; Prins J; Konsman JP; Korte-Bouws GA; Westphal KG; Rybka J; Olivier B; Kraneveld AD; Korte SM
Eur J Pharmacol; 2014 Feb; 725():55-63. PubMed ID: 24444442
[TBL] [Abstract][Full Text] [Related]
31. Hypericum perforatum L (St John's wort) preferentially increases extracellular dopamine levels in the rat prefrontal cortex.
Yoshitake T; Iizuka R; Yoshitake S; Weikop P; Müller WE; Ogren SO; Kehr J
Br J Pharmacol; 2004 Jun; 142(3):414-8. PubMed ID: 15148244
[TBL] [Abstract][Full Text] [Related]
32. Loxiglumide, L-364,718 and L-365,260 prevent the inhibition of spontaneous acetylcholine release from the frontal cerebral cortex of freely moving rat peripherally administered with cholecystokinin-8S.
Kimura I; Wakasono S; Kimura M
Jpn J Pharmacol; 1995 May; 68(1):129-32. PubMed ID: 7494376
[TBL] [Abstract][Full Text] [Related]
33. Ceruletide, a cholecystokinin-related peptide, attenuates haloperidol-induced increase in dopamine release from the rat striatum: an in vivo microdialysis study.
Kihara T; Ikeda M; Matsushita A
Brain Res; 1990 Jun; 519(1-2):44-9. PubMed ID: 2397417
[TBL] [Abstract][Full Text] [Related]
34. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
[TBL] [Abstract][Full Text] [Related]
35. Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex.
Devoto P; Flore G; Saba P; Frau R; Gessa GL
Brain Behav; 2015 Oct; 5(10):e00393. PubMed ID: 26516613
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous determination of cholecystokinin-like immunoreactivity and dopamine release after treatment with veratrine, NMDA, scopolamine and SCH23390 in rat medial frontal cortex: a brain microdialysis study.
Liu JK; Kato T
Brain Res; 1996 Sep; 735(1):30-5. PubMed ID: 8905166
[TBL] [Abstract][Full Text] [Related]
37. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats.
Ladurelle N; Keller G; Blommaert A; Roques BP; Daugé V
Eur J Neurosci; 1997 Sep; 9(9):1804-14. PubMed ID: 9383203
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex.
Devoto P; Flore G; Saba P; Fà M; Gessa GL
J Neurochem; 2005 Jan; 92(2):368-74. PubMed ID: 15663484
[TBL] [Abstract][Full Text] [Related]
39. Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex.
Ago Y; Nakamura S; Baba A; Matsuda T
Neuropsychopharmacology; 2005 Jan; 30(1):43-51. PubMed ID: 15383832
[TBL] [Abstract][Full Text] [Related]
40. Ceruletide suppresses rotational behavior in lesioned rats via CCKA receptors.
Fujisawa M; Miyamoto O; Itano T; Tokuda M; Matsui H; Nagao S; Negi T; Hatase O
Eur J Pharmacol; 1993 Jul; 238(1):127-30. PubMed ID: 8405076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
